CAPRIOLI, FLAVIO ANDREA

CAPRIOLI, FLAVIO ANDREA  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 209 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Risankizumab, but not ustekinumab or vedolizumab, downregulates IL-23-induced mucosal pathogenic Th17 cells in patients with Crohn’s disease 2024 Noviello, DDusetti, ICiafardini, CConforti, FPiazza O Sed, NVecchi, MParoni, MCaprioli, F + Article (author) -
Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics: a multicenter observational study 2024 Noviello, DanieleCaprioli, Flavio + Article (author) -
Costo per Number Needed to Treat (NNT) di upadacitinib nel trattamento dei pazienti bio-exposed con rettocolite ulcerosa attiva da moderata a grave 2024 Caprioli, Flavio + Article (author) -
Pragmatic trial design to compare real-world effectiveness of different treatments for inflammatory bowel diseases: the PRACTICE-IBD European consensus 2024 Flavio Andrea Caprioli + Article (author) -
Timing of proper introduction, optimization and maintenance of anti-TNF therapy in IBD: Results from a Delphi consensus 2024 Caprioli, Flavio + Article (author) -
Role of the Microbiome in the Diagnosis and Management of Gastroesophageal Cancers 2024 Caprioli, Flavio + Article (author) -
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD) 2024 Caprioli, FlavioVecchi, Maurizio + Article (author) -
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study 2024 Noviello, DanieleCaprioli, Flavio + Article (author) -
Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian Study 2024 Carvalhas Gabrielli, Anna MariaTombetti, EnricoMaconi, GiovanniCaprioli, Flavio + Article (author) -
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus 2024 Caprioli, FlavioCaporali, RobertoMariani, Paolo + Article (author) -
Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study 2023 Caprioli, Flavio + Article (author) -
Superior predictive value of transmural over endoscopic severity for colectomy risk in ulcerative colitis: a multicenter prospective cohort study 2023 Daniele NovielloElisabetta FilippiFrancesco ConfortiAndrea CostantinoMaurizio VecchiMariangela AlloccaDaniele NovielloElisabetta FilippiFrancesco ConfortiFederica FurfaroAndrea CostantinoMaurizio VecchiFlavio Caprioli + Article (author) -
Nutritional care at centres managing patients with inflammatory bowel disease: A nationwide survey in Italy 2023 Caprioli, Flavio + Article (author) -
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 2023 Caprioli, Flavio + Article (author) -
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology 2023 Caprioli, Flavio + Article (author) -
The Bowel-Associated Arthritis-Dermatosis Syndrome (BADAS): A Systematic Review 2023 Aromolo, Italo FrancescoSimeoli, DomenicoMaronese, Carlo AlbertoAltomare, AndreaNoviello, DanieleCaprioli, FlavioMarzano, Angelo Valerio Article (author) -
Prevalence of Disease-Related Malnutrition and Micronutrients Deficit in Patients with Inflammatory Bowel Disease: A Multicentric Cross-Sectional Study by the GSMII (Inflammatory Bowel Disease Study Group) 2023 Pastorelli, LucaCaprioli, Flavio AndreaVecchi, Maurizio + Article (author) -
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 2023 Caprioli, Flavio AndreaPastorelli, Luca + Article (author) -
Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease 2023 Pastorelli, LucaCaprioli, Flavio AndreaArdizzone, SandroTontini, Gian EugenioVecchi, Maurizio + Article (author) -
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease 2023 Pastorelli L.Caprioli F. + Article (author) -